Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
Eric J. Haas(Israel Ministry of Health), Frederick J. Angulo(Pfizer (United States)), John M. McLaughlin(Pfizer (United States)), Emilia Anis(Israel Ministry of Health), Shepherd Roee Singer(Hebrew University of Jerusalem), Farid Khan(Pfizer (United States)), Nati Brooks(Israel Ministry of Health), Meir Smaja(Israel Ministry of Health), Gabriel Mircus, Kaijie Pan(Pfizer (United States)), Jo Southern(Pfizer (United States)), David L. Swerdlow(Pfizer (United States)), Luis Jódar(Pfizer (United States)), Yeheskel Levy(Israel Ministry of Health), Sharon Alroy‐Preis(Israel Ministry of Health)
Cited by 1,748Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis